I obtained a PhD degree in Biochemistry from the North-West University with a thesis titled “Tyrosinemia type I as a model for studying epigenetic events in the aetiology of metabolic disease associated hepatocarcinoma” in 2012. After completion of my PhD, I commenced with a postdoctoral fellowship in the field of Pharmaceutics in the Unit for Drug Research and Development, now the Centre of Excellence for Pharmaceutical Sciences (Pharmacen™).